Found 4 matching trials
Neo-MASCT Immunotherapy for Advanced NSCLC.
PHASE1Neoantigen (Neo)is a new targets for immune cells,that the DC neoantigen im...
MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma
PHASE2This study will evaluate the safety and efficacy of MASCT-I combined with D...
Location
Sun Yat-sen University Cancer Center
MASCT-I Combined With Apatinib and/or Camrelizumab in the Treatment of Bone and Soft Tissue Sarcoma
EARLY_PHASE1This study will evaluate the safety and preliminary efficacy of Multi-Antig...
Location
Shanghai Sixth People's Hospital
MASCT-I in Patients With Metastatic or Recurrent Solid Tumors Who Failed Standard Therapy.
PHASE1The purpose of this study is to evaluate the safety and tolerability of MAS...
Location
Sun Yat-sen University Cancer Center